Barinthus Biotherapeutics plc (BRNS)
BRNS · Pharmaceutical Preparations · Germantown, MD · filing with the SEC since 2020
Who owns Barinthus Biotherapeutics plc
As filed with the SECHolders of 5% or more
2
Frank W. Cawood holds 8.4% of American Depositary Shares, each representing one ordinary share, as its SCHEDULE 13G/A filed Feb 11, 2025 says.
Directors and officers
9
report now, of 17 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Frank W. Cawood
SCHEDULE 13G/A · filed Feb 11, 2025 · American Depositary Shares, each representing one ordinary share
International Generosity Foundation Trust
SCHEDULE 13D · filed Apr 13, 2026 · Common Stock
Oxford Science Enterprises plc
SCHEDULE 13G/A · filed Sep 11, 2026 · American Depositary Shares, each representing one Ordinary Share · reported falling below 5%
What BRNS reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Becaon Topco, Inc
An entity · legal entity · owns, named in the 10-K filed Mar 13, 2026
Clywedog Therapeutics, Inc.
An entity · legal entity · owns, named in the 10-K filed Mar 13, 2026
7 subsidiaries in 4 countries, from the list filed with the 10-K filed Mar 13, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2023 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.